![Harry Sacks](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Storia della carriera di Harry Sacks
Precedenti posizioni note di Harry Sacks
Società | Posizione | Inizio | Fine |
---|---|---|---|
OPTINOSE, INC. | Direttore Tecnico/Scientifico/R&S | 01/10/2017 | 01/10/2022 |
NOVARTIS AG | Direttore Tecnico/Scientifico/R&S | 01/09/2012 | - |
Edge Therapeutics, Inc.
![]() Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | Corporate Officer/Principal | 01/06/2016 | - |
FOREST LABORATORIES, INC. | Corporate Officer/Principal | - | - |
Formazione di Harry Sacks
Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Svizzera | 2 |
Posizioni
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Settori
Health Technology | 5 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
OPTINOSE, INC. | Health Technology |
NOVARTIS AG | Health Technology |
Aziende private | 2 |
---|---|
Forest Laboratories, Inc.
![]() Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |
Edge Therapeutics, Inc.
![]() Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | Health Technology |
- Borsa valori
- Insiders
- Harry Sacks
- Esperienza